(1)
Controlled Release Matrix Formulation of Paliperidone in Concurrence With Regulatory Requirements. Int. J. Pharm. Sci. Drug Res. 2023, 15 (4), 426-431. https://doi.org/10.25004/IJPSDR.2023.150405.